The DOI matches its Crossref record; 3,517 of the 3,517 references it cites were found in a registry or an index.
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 2,801–3,000 of 3,517
Overexpression of Alpha2C-adrenoceptors impairs water maze navigation
Björklund, M., Sirviö, J., Riekkinen, M., Sallinen, J., Scheinin, M., & Riekkinen, P. J. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00428-5 · Cited by 49
Voderholzer, U., Laakmann, G., Wittmann, R., Daffner, C., Hinz, A., Haag, C., & Baghai, T. C. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90080-z · Cited by 49
Safety of antidepressants in the elderly
Sommer, B. R., Fenn, H. H., Pompei, P., DeBattista, C., Lembke, A., Wang, P. W., & Flores, B. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.4.367 · Cited by 49
Millan, M. J., Brocco, M., Rivet, J., Audinot, V., Newman‐Tancredi, A., Maiofiss, L., Queriaux, S., Despaux, N., Péglion, J.-L., & Dekeyne, A. (2000) · PubMed · Cited by 49
Self-citationStrategies for managing sexual dysfunction induced by antidepressant medication
Rudkin, L., Taylor, M. J., & Hawton, K. K. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003382.pub2 · Cited by 49
Effects of trazodone hydrochloride and imipramine on polysomnography in healthy subjects
YAMADERA, H., NAKAMURA, S., SUZUKI, H., & ENDO, S. (1998) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.1998.00403.x · Cited by 48
Kuczewski, N., Aztiria, E., Gautam, D., Wess, J., & Domenici, L. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.089987 · Cited by 48
Giedke, H., Klingberg, S., Schwärzler, F., & Schweinsberg, M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00071-x · Cited by 48
Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice
Pan, Y., Gembom, E., Peng, W., Lesch, K., Mößner, R., & Simantov, R. (2001) · Developmental Brain Research · doi:10.1016/s0165-3806(00)00145-0 · Cited by 48
Endersby, C. A., & WILSON, C. A. (1974) · Brain Research · doi:10.1016/0006-8993(74)91052-x · Cited by 48
1 Growth hormone deficiency and cardiovascular risk
Hew, F. L., O'Neal, D. N., Kamarudin, N., ALFORD, F. P., & Best, J. D. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80018-9 · Cited by 48
Kraus, M. M., & Prast, H. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00079-9 · Cited by 48
Nair, S. G., & Gudelsky, G. A. (2004) · Synapse · doi:10.1002/syn.20054 · Cited by 48
Treatment of dementia with neurotransmission modulation
Doggrell, S. A., & Evans, S. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.10.1633 · Cited by 48
Thomas, L. S., Jane, D. E., Gasparini, F., & Croucher, M. J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00091-0 · Cited by 48
The effects of reboxetine on autonomic and cognitive functions in healthy volunteers
Siepmann, M., ck-Weymann, M. M. X. F., Joraschky, P., & Kirch, W. (2001) · Psychopharmacology · doi:10.1007/s002130100791 · Cited by 48
Moresco, R. M., Colombo, C., Fazio, F., Bonfanti, A., Lucignani, G., Messa, C., Gobbo, C., Galli, L., Sole, A. D., Lucca, A., et al. (2000) · NeuroImage · doi:10.1006/nimg.2000.0619 · Cited by 48
Berendsen, H. H. G., & Broekkamp, C. L. E. (1991) · Psychopharmacology · doi:10.1007/bf02244313 · Cited by 48
A comparative study of milnacipran and paroxetine in outpatients with major depression
Sechter, D., Vandel, P., Weiller, E., Pezous, N., Cabanac, F., & Tournoux, A. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.07.002 · Cited by 48
Buspirone and Imipramine for the Treatment of Major Depression in the Elderly
Schweizer, E. E., Rickels, K., Hassman, H. H., & García‐España, F. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0406 · Cited by 48
Panocka, I., Massi, M. N., Łapo, I. B., Swiderski, T., Kowalczyk, M., & Sadowski, B. (2001) · Peptides · doi:10.1016/s0196-9781(01)00438-7 · Cited by 48
Huang, G., & Herbert, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300609 · Cited by 48
Occupancy of Agonist Drugs at the 5-HT1A Receptor
Bantick, R. A., Rabiner, E. A., Hirani, E., de Vries, M. H., Hume, S. P., & Grasby, P. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300390 · Cited by 48
Marchand, F., Alloui, A., Chapuy, E., Jourdan, D., Pélissier, T., Ardid, D., Hernández, A., & Eschalier, A. (2003) · Pain · doi:10.1016/s0304-3959(03)00168-4 · Cited by 48
Castanon, N., Konsman, J. P., Medina, C. F., Chauvet, N., & Dantzer, R. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00005-7 · Cited by 48
Millan, M. J., Cara, B. D., Hill, M. P., Jackson, M., Joyce, J. N., Brotchie, J. M., McGuire, S., Crossman, A. R., Smith, L. A., Jenner, P. G., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062414 · Cited by 48
Self-citationLorrain, D. S., Matuszewich, L., & Hull, E. M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00065-1 · Cited by 48
Special issues in the management of depression in women.
MacQUEEN, G. M., & Chokka, P. R. (2004) · PubMed · Cited by 48
Circadian profiles of cortisol, prolactin, and thyrotropin in seasonal affective disorder
Oren, D. A., Levendosky, A. A., Kasper, S. F., Duncan, C. C., & Rosenthal, N. E. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00079-8 · Cited by 48
Pramipexole Augmentation of a Selective Serotonin Reuptake Inhibitor in the Treatment of Depression
DeBattista, C., Solvason, H. B., Breen, J. A. H., & Schatzberg, A. F. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00029 · Cited by 48
Neurochemical and Pharmacological Properties of Tianeptine, A Novel Antidepressant
Labrid, C., Mocaër, E., & Kamoun, A. (1992) · The British Journal of Psychiatry · doi:10.1192/s0007125000296694 · Cited by 48
GABAA-receptor plasticity during long-term exposure to and withdrawal from progesterone
Biggio, G., Follesa, P., Sanna, E., Purdy, R. H., & Concas, A. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46064-8 · Cited by 47
Page, M. E., Brown, K., & Lucki, I. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1269-x · Cited by 47
Silverstone, P. H., Rue, J. E., Franklin, M., Hallis, K. F., Camplin, G., Laver, D. A., & Cowen, P. J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199409000-00005 · Cited by 47
Lall, G. S., & Biello, S. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00811-4 · Cited by 47
Reinforcing effects of the neurosteroid allopregnanolone in rats
Sinnott, R. S., Mark, G. P., & Finn, D. A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00776-1 · Cited by 47
Lamirault, L., Guillou, C., Thal, C., & Simon, H. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00351-2 · Cited by 47
Mihara, K., Yasui‐Furukori, N., Kondo, T., Ishida, M., Ono, S., Ohkubo, T., Osanai, T., Sugawara, K., Otani, K., & Kaneko, S. (2002) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200208000-00016 · Cited by 47
The generation of nitric oxide by G protein-coupled receptors
Christopoulos, A., & El‐Fakahany, E. E. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00348-8 · Cited by 47
Patel, J. G., Bartoszyk, G. D., Edwards, E., & Ashby, C. R. (2004) · Synapse · doi:10.1002/syn.10308 · Cited by 47
Millan, M. J., Veiga, S., Girardon, S., & Brocco, M. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1389-y · Cited by 47
Self-citationIn vivo assessment of the effects of estrogen on human brain
van Amelsvoort, T., Compton, J., & Murphy, D. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00422-2 · Cited by 47
Eighty percent of proteins are different between humans and chimpanzees
Glazko, G. V., Veeramachaneni, V., Nei, M., & Makałowski, W. (2005) · Gene · doi:10.1016/j.gene.2004.11.003 · Cited by 47
Vascular Risk to Late-Life Depression: Evidence from a Longitudinal Community Study
Hickie, I. B., Simons, L. A., Naismith, S. L., Simons, J., McCallum, J. C., & Pearson, K. (2003) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2003.01105.x · Cited by 47
Payne, J. L., Quiroz, J. A., Zarate, C. A., & Manji, H. K. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01676-1 · Cited by 46
Swanson, C. J., Perry, K. W., & Schoepp, D. D. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02125.x · Cited by 46
On the dual nature of chance in evolutionary biology and paleobiology
Eble, G. J. (1999) · Paleobiology · doi:10.1666/0094-8373(1999)025<0075:otdnoc>2.3.co;2 · Cited by 46
Pramipexole in Refractory Bipolar Depression
Goldberg, J. F., Frye, M. A., & Dunn, R. T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.798 · Cited by 46
Wollnik, F. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90190-q · Cited by 46
Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523
Tottori, K., Miwa, T., Uwahodo, Y., Yamada, S., Nakai, M., Oshiro, Y., Kikuchi, T., & Altar, C. A. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00147-2 · Cited by 46
Chiavegatto, S., Scavone, C., & Canteras, N. S. (1998) · Neuroreport · doi:10.1097/00001756-199803090-00002 · Cited by 46
Beneficial Treatment of Age-Related Sleep Disturbances With Prolonged Intranasal Vasopressin
Perras, B., Pannenborg, H., Marshall, L., Pietrowsky, R., Born, J., & Fehm, H. L. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00007 · Cited by 46
Bitner, R. S., & Nikkel, A. L. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02485-x · Cited by 46
Tatarczynska, E., Antkiewicz‐Michaluk, L., Kłodzińska, A., Stachowicz, K., & Chojnacka-Wójcik, E. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.04.025 · Cited by 46
Mallick, B. N., Singh, S., & Pal, D. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.08.004 · Cited by 46
Millan, M. J., Girardon, S., Mullot, J., Brocco, M., & Dekeyne, A. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00021-7 · Cited by 46
Self-citationKodama, M., Russell, D., & Duman, R. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300588 · Cited by 46
Westerink, B. H. C. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02496-2 · Cited by 46
Antidepressant Properties of Substance P Antagonists: Relationship to Monoaminergic Mechanisms?
Adell, A. (2004) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007043482516 · Cited by 46
Du, J., Szabo, S. T., Gray, N. A., & Manji, H. K. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004432 · Cited by 46
Inhibitory effects of trace amines on rat midbrain dopaminergic neurons
Geracitano, R., Federici, M., Prisco, S., Bernardi, G., & Mercuri, N. B. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.11.031 · Cited by 46
Silverdale, M., Nicholson, S. L., Ravenscroft, P., Crossman, A. R., Millan, M. J., & Brotchie, J. M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.03.022 · Cited by 46
Self-citationBengtsson, H. J., Kele, J., Johansson, J., & Hjorth, S. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000294 · Cited by 46
Sotomayor, R., Forray, M. I., & Gysling, K. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20537 · Cited by 45
The use of thyroid supplements to augment antidepressant medication.
Joffe, R. T. (1998) · PubMed · Cited by 45
Beyond the Treatment of Epilepsy: New Applications of Vagus Nerve Stimulation in Psychiatry
Kosel, M., & Schlaepfer, T. E. (2003) · CNS Spectrums · doi:10.1017/s1092852900018988 · Cited by 45
Could the 5-HT1B receptor inverse agonism affect learning consolidation?
Meneses, A. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00007-0 · Cited by 45
An Affinity‐Modulating Site on Neuronal Monoamine Transport Proteins
Plenge, P., & Mellerup, E. T. (1997) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1997.tb00396.x · Cited by 45
Ferraro, L., Fuxé, K., Agnati, L. F., Tanganelli, S., Tomasini, M. C., & Antonelli, T. (2005) · Synapse · doi:10.1002/syn.20111 · Cited by 45
Kopp, C., Vogel, E., Rettori, M., Delagrange, P., & Misslin, R. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00263-4 · Cited by 45
Rabadan‐Diehl, C., Makara, G. B., Kiss, A., Lolait, S. J., Zelena, D., Ochędalski, T., & Aguilera, G. (1997) · Endocrinology · doi:10.1210/endo.138.12.5580 · Cited by 45
Fernández‐Guasti, A., & Escalante, A. (1991) · Journal of Neural Transmission · doi:10.1007/bf01244702 · Cited by 45
Praschak-Rieder, N., Hussey, D., Wilson, A. A., Carella, A., Lee, M., Dunn, E. J., Willeit, M., Bagby, R. M., Houle, S., & Meyer, J. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.018 · Cited by 45
Varcoe, T. J., Kennaway, D. J., & Voultsios, A. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.09.010 · Cited by 45
McElroy, J., Ward, K., Zeller, K. L., Jones, K., Gilligan, P. J., He, L., & Lelas, S. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1239-3 · Cited by 45
Treatment of depression and concomitant anxiety
Nutt, D. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00110-3 · Cited by 45
Cusack, B. P., & Wolfe, K. H. (2005) · Molecular Biology and Evolution · doi:10.1093/molbev/msi218 · Cited by 45
Ahmad, S., Fowler, L. J., & Whitton, P. S. (2005) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-1008-4 · Cited by 45
Raven, P., Checkley, S. A., & Taylor, N. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02930.x · Cited by 45
Evidence-based pharmacotherapy of panic disorder
Bakker, A., van Balkom, A. J. L. M., & Stein, D. J. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005201 · Cited by 45
Organic cation transporter mRNA and function in the rat superior cervical ganglion
Kristufek, D., Rudorfer, W., Pifl, C., & Huck, S. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.021170 · Cited by 45
Selective effects of clonidine and temazepam on attention and memory
Tiplady, B., Bowness, E., Stien, L., & Drummond, G. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105051529 · Cited by 45
Szegedi, A., Hillert, A., Wetzel, H., Klieser, E., Gäebel, W., & Benkert, O. (1997) · Clinical Neuropharmacology · doi:10.1097/00002826-199720001-00006 · Cited by 45
Sprouse, J., Reynolds, L., Braselton, J., & Schmidt, A. (2004) · Synapse · doi:10.1002/syn.20070 · Cited by 44
Treating depression to remission.
Zajecka, J. (2003) · PubMed · Cited by 44
Ichikawa, J., Dai, J., & Meltzer, H. Y. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.005 · Cited by 44
Torres-Escalante, J. L., Barral, J. A., Ibarra‐Villa, M. D., Pérez‐Burgos, A., Góngora-Alfaro, J. L., & Pineda, J. C. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20247 · Cited by 44
Urani, A., Romieu, P., Portales-Casamar, É., Roman, F. J., & Maurice, T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1150-y · Cited by 44
Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil
Zhu, C.-B., Hewlett, W. A., Francis, S. H., Corbin, J. D., & Blakely, R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.09.023 · Cited by 44
Melatonin reduces anxiety induced by lipopolysaccharide in the rat
Nava, F. A., & Carta, G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01930-9 · Cited by 44
Successful Treatment of Fluvoxamine-Induced Anorgasmia by Cyproheptadine
Arnott, S., & Nutt, D. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.6.838 · Cited by 44
Estrogen mediated inhibition of dopamine transport in the striatum: Regulation by Gαi/o
Thompson, T. L., & Certain, M. E. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.005 · Cited by 44
Amici, R., Sanford, L. D., Kearney, K., McInerney, B., Ross, R. J. M., Horner, R. L., & Morrison, A. R. (2003) · Brain Research · doi:10.1016/j.brainres.2003.09.026 · Cited by 44
Kennaway, D. J., Moyer, R. W., Voultsios, A., & Varcoe, T. J. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02091-1 · Cited by 44
Improving Alzheimer's disease-related cognitive deficits with sigma1 receptor agonists
Maurice, T. (2002) · Drug News & Perspectives · doi:10.1358/dnp.2002.15.10.740241 · Cited by 44
Nava, F. A., Carta, G., Bortolato, M., & Gessa, G. L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01163-3 · Cited by 44
Duncan, M. J., Jennes, L., Jefferson, J. B., & Brownfield, M. S. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02383-0 · Cited by 44
Rupprecht, R., Ströhle, A., Hermann, B., di Michele, F., Spalletta, G., Pasini, A., Holsboer, F., & Romeo, E. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00521-0 · Cited by 44
Influence of sildenafil on central dopamine-mediated behaviour in male rats
Ferrari, F., Ottani, A., & Giuliani, D. (2002) · Life Sciences · doi:10.1016/s0024-3205(01)01515-6 · Cited by 44
Clénet, F., Vos, A. D., & Bourin, M. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00078-5 · Cited by 44
Lockhart, B. P., & Lestage, P. J. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00163-8 · Cited by 44
Cryan, J. F., & Lucki, I. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00858-x · Cited by 44
Licht-Strunk, E., Bremmer, M. A., van Marwijk, H., Deeg, D. J. H., Hoogendijk, W. J. G., de Haan, M., van Tilburg, W., & Beekman, A. T. F. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.06.007 · Cited by 44
Neuroprotective properties of tianeptine: interactions with cytokines
Plaisant, F., Dommergues, M.-A., Spedding, M., Cecchelli, R., Brillault, J., Kato, G., Muñoz, C., & Gressèns, P. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00066-2 · Cited by 44
Wu, M., Newton, S. S., Atkins, J. B., Xu, C., Duman, R. S., & Alreja, M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052514 · Cited by 44
Circadian rhythms and sleep regulation in seasonal affective disorder
Wirz‐Justice, A., Kräuchi, K., Brunner, D. P., Graw, P., Haug, H.-J., Leonhardt, G., Sarrafzadeh, A. S., English, J., & Arendt, J. (1995) · Acta Neuropsychiatrica · doi:10.1017/s0924270800037522 · Cited by 44
Nathan, P. J., Sitaram, G., Stough, C., Silberstein, R. B., & Sali, A. (2000) · Behavioral Pharmacology · doi:10.1097/00008877-200011000-00011 · Cited by 43
Expression of the extraneuronal monoamine transporter (uptake2) in human glioma cells
Streich, S., Miss, M.-T., & B�nisch, H. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168636 · Cited by 43
Novi, F., Scarselli, M., Corsini, G. U., & Maggio, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306818200 · Cited by 43
Regulatory role of nitric oxide over hippocampal 5-HT release in vivo
Segieth, J., Pearce, B., Fowler, L. J., & Whitton, P. S. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000370 · Cited by 43
SSRI treatment decreases prolactin and hyperthermic responses to mCPP
Quested, D. J., Sargent, P. A., & Cowen, P. J. (1997) · Psychopharmacology · doi:10.1007/s002130050406 · Cited by 43
Involvement of bulbospinal pathways in the antinociceptive effect of clomipramine in the rat
Ardid, D., Jourdan, D., Mestre, C., Villanueva, L., Bars, D. L., & Eschalier, A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00826-c · Cited by 43
Thomas, E., Pernar, L. I. M., Lucki, I., & Valentino, R. J. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03882-9 · Cited by 43
Do dopamine agonists or levodopa modify Parkinson's disease progression?
MAREK, K. L., Jennings, D. L., & Seibyl, J. P. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.9.s3.2.x · Cited by 43
Kaye, D. M., Gruskin, S., Smith, A. I., & Esler, M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703416 · Cited by 43
On the role of endogenous GABA in the forced swimming test in rats
Borsini, F., Mancinelli, A., D'Aranno, V., Evangelista, S., & Meli, A. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90156-6 · Cited by 43
Zullino, D., & Baumann, P. (2001) · Pharmacopsychiatry · doi:10.1055/s-2001-15873 · Cited by 43
The effect of oestradiol dipropionate and progesterone on monoamioe uptake in rat brain1
Wirz‐Justice, A., Hackmann, E., & Lichtsteiner, M. (1974) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1974.tb12198.x · Cited by 43
Brassen, S., Braus, D. F., Weber-Fahr, W., Tost, H., Moritz, S., & Adler, G. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000080028 · Cited by 43
Antidepressant drugs: does it matter if they inhibit the reuptake of noradrenaline or serotonin?
Eriksson, E. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.00003.x · Cited by 43
Nayebi, A. M., Hassanpour, M., & Rezazadeh, H. (2001) · The Journal of pharmacy and pharmacology · doi:10.1211/0022357011775235 · Cited by 43
Chistyakov, A. V., Kaplan, B., Rubichek, O., Kreinin, I., Koren, D., Feinsod, M., & Klein, E. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004912 · Cited by 43
Proteomics of multiprotein complexes: answering fundamental questions in neuroscience
Grant, S. G. N., & Husi, H. (2001) · Trends in biotechnology · doi:10.1016/s0167-7799(01)01799-1 · Cited by 43
Effect of acute tryptophan depletion on the response to controllable and uncontrollable noise stress
Richell, R. A., Deakin, J. F. W., & Anderson, I. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.010 · Cited by 43
Anatomy of Central Serotoninergic Projection Systems
Baumgarten, H. G., & Grozdanovic, Z. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60921-3_2 · Cited by 43
Tricyclic side effects without tricyclics in depression.
Mathew, R. J., Weinman, M. L., & Jl, C. (1980) · PubMed · Cited by 43
Saux, M. L., & Paolo, T. D. (2005) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0517 · Cited by 43
5-HT2A antagonists in psychiatric disorders.
Angelis, L. D. (2002) · PubMed · Cited by 42
Jamerson, B. D., PharmD, Krishnan, K. R. R., MB, ChB, Roberts, J., MS, Krishen, A., MSc, MS, et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4185 · Cited by 42
The further evolution of biotech
Nagle, T., Berg, C., Nassr, R., & Pang, K. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd989 · Cited by 42
Effect of SB-243213, a selective 5-HT2C receptor antagonist, on the rat sleep profile
Smith, M. I., Piper, D. C., Duxon, M. S., & Upton, N. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00702-x · Cited by 42
Discriminative stimulus properties of mCPP: evidence for a 5-HT 2C receptor mode of action
Gommans, J., Hijzen, T. H., Maes, R. A. A., & Olivier, B. (1998) · Psychopharmacology · doi:10.1007/s002130050622 · Cited by 42
Once-daily high-dose pindolol for SSRI-refractory depression
Sokolski, K. N., Conney, J. C., Brown, B., & DeMet, E. M. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2003.12.006 · Cited by 42
Effect of Antidepressant Medication Resistance on Short-term Response to Electroconvulsive Therapy
van den Broek, W. W., de Lely, A., Mulder, P. G. H., Birkenhäger, T. K., & Bruijn, J. A. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000130551.70878.56 · Cited by 42
Makatsori, A., Dunčko, R., Moncek, F., Loder, I., Katina, S., & Ježová, D. (2004) · Neuroendocrinology · doi:10.1159/000076045 · Cited by 42
Decreased GABA B Receptors in Helpless Rats: Reversal by Tricyclic Antidepressants
Martin, P., Pichat, P., Massol, J., Soubrié, P., Lloyd, K. G., & Puech, A. J. (2008) · Neuropsychobiology · doi:10.1159/000118620 · Cited by 42
Tuinhof, R., Laurent, F. Y. S. C., Ebbers, R. G. E., Smeets, W. J. A. J., van Riel, M. C. H. M., & Roubos, E. W. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90432-f · Cited by 42
Is the GABAB Heterodimer a Good Drug Target?
Marshall, F. H. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:26:2-3:169 · Cited by 42
Circadian rhythm sleep disorders
Reid, K. J., Chang, A., & Zee, P. C. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.01.010 · Cited by 42
Pinna, G., Brödel, O., Eravci, M., Stoltenburg, G., Plueckhan, H., Fuxius, S., MEINHOLD, H., & Baumgartner, A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00414-1 · Cited by 42
Vivian, J. A., & Miczek, K. A. (1999) · Psychopharmacology · doi:10.1007/s002130051101 · Cited by 42
Bueno, C. H., Zangrossi, H., Nogueira, R. L., Soares-Rachetti, V. D. P., & Viana, M. D. B. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.04.045 · Cited by 42
Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat
Marchand, F., Alloui, A., Pélissier, T., Hernández, A., Authier, N., Álvarez, P., Eschalier, A., & Ardid, D. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02946-9 · Cited by 42
Koorengevel, K. M., Beersma, D. G. M., den Boer, J. A., & van den Hoofdakker, R. H. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(02)00305-0 · Cited by 42
Martínez, J. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(00)01198-3 · Cited by 42
Ansah, T.-A., Ramamoorthy, S., Montañez, S., Daws, L. C., & Blakely, R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047134 · Cited by 42
Murphy, B. E. P., GHADIRIAN, A. M., & Dhar, V. (1998) · The Canadian Journal of Psychiatry · doi:10.1177/070674379804300307 · Cited by 42
Fluoxetine-Maintained Obese Humans
Ward, A. S., Comer, S. D., Haney, M., Fischman, M. W., & Foltin, R. W. (1999) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00020-7 · Cited by 41
Mercuri, N. B., Scarponi, M., Bonci, A., Siniscalchi, A., & Bernardi, G. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02267.1997 · Cited by 41
Effect of antidepressants on GABAB receptor function and subunit expression in rat hippocampus
Sands, S. A., Reisman, S. A., & Enna, S. J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.027 · Cited by 41
Parini, S., Renoldi, G., Battaglia, A., & Invernizzi, R. W. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300661 · Cited by 41
Albinsson, A., Björk, A., Svartengren, J., Klint, T., & Andersson, G. K. A. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90119-8 · Cited by 41
Berrocoso, E., Rojas-Corrales, M. O., & Micó, J. A. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.03.041 · Cited by 41
Moser, P. C., & Sanger, D. J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00202-2 · Cited by 41
Agonist-specific regulation of the δ-opioid receptor
Varga, E. V., Navratilova, E., Stropova, D., et al. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.07.020 · Cited by 41
Kardos, J., Elster, L., Damgaard, I., Krogsgaard‐Larsen, P., & Schousboe, A. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390604 · Cited by 41
Kampen, J. M. V., & Stoessl, A. J. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00548-1 · Cited by 41
Gannon, R. L. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00161-1 · Cited by 41
Angel, I., Schoemaker, H., Prouteau, M., Garreau, M., & Langer, S. Z. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90767-c · Cited by 41
Farvolden, P., Kennedy, S. H., & Lam, R. W. M. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.1.65 · Cited by 41
REM Sleep Effects as a Biomarker for the Effects of Antidepressants in Healthy Volunteers
Rijnbeek, B., de Visser, S. J., Franson, K. L., Cohen, A., & van Gerven, J. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017002008 · Cited by 41
Therapeutic Potential of 5-HT2C Receptor Antagonists in the Treatment of Anxiety Disorders
Wood, M. D. (2003) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007033482698 · Cited by 41
Wirkner, K., Krause, T., Köles, L., Thümmler, S., Al‐Khrasani, M., & Illés, P. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.015 · Cited by 41
Sun, B., Chen, X., Lu, X., Sterling, C. R., & Tank, A. W. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001974 · Cited by 41
New hope in the treatment of painful symptoms in depression.
Briley, M. (2003) · PubMed · Cited by 41
Posternak, M. A., & Zimmerman, M. A. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0212 · Cited by 40
Soto‐Moyano, R., Valladares, L., Sierralta, W. D., Pérez, H., Mondaca, M., Fernández, V., Burgos, H., & Hernández, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03094.x · Cited by 40
Effects of scopolamine and d-cycloserine on non-spatial reference memory in rats
Andersen, J. M., Lindberg, V., & Myhrer, T. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00318-7 · Cited by 40
Idazoxan potentiates rather than antagonizes some of the cognitive effects of clonidine
Middleton, H. C., Sharma, A., Agouzoul, D., Sahakian, B. J., & Robbins, T. W. (1999) · Psychopharmacology · doi:10.1007/s002130051074 · Cited by 40
Pharmacological Features of Masculine Sexual Behavior in an Animal Model of Depression
Bonilla‐Jaime, H., Retana‐Márquez, S., & Velázquez‐Moctezuma, J. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00484-x · Cited by 40
Agonist trafficking of Gi/o‐mediated α2A‐adrenoceptor responses in HEL 92.1.7 cells
Kukkonen, J. P., Jansson, C. C., & Åkerman, K. E. O. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703964 · Cited by 40
Takeuchi, H., Yatsugi, S., Hatanaka, K.-I., et al. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)10108-x · Cited by 40
Nongenomic steroidal modulation of high-affinity serotonin transport
Chang, A. S., & Chang, S. M. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00255-7 · Cited by 40
Acquas, E., Day, J. C., & Fibiger, H. C. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90013-2 · Cited by 40
Sebban, C., Tesolin, B., Millan, M. J., & Spedding, M. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702893 · Cited by 40
Self-citationTowards the pharmacotherapy of eating disorders
Pederson, K. J., Roerig, J. L., & Mitchell, J. E. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.10.1659 · Cited by 40
Kawabe, K., Yoshihara, T., Ichitani, Y., & Iwasaki, T. (1998) · Brain Research · doi:10.1016/s0006-8993(98)01043-9 · Cited by 40
Kamisaki, Y., Hamahashi, T., Okada, C. M., & Itoh, T. (1991) · Brain Research · doi:10.1016/0006-8993(91)91397-j · Cited by 40
Molina-Hernández, M., Téllez-Alcántara, N. P., García, J. P., Lopez, J. I. O., & Jaramillo, M. T. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.11.017 · Cited by 40
The Augmentation Hypothesis for Improvement of Antidepressant Therapy
Kinney, G. G., Taber, M. T., & Gribkoff, V. K. (2000) · Molecular Neurobiology · doi:10.1385/mn:21:3:137 · Cited by 40
Role of 5-HT1A and 5-HT1B receptors in the antinociceptive effect of tramadol
Rojas-Corrales, M. O., Berrocoso, E., & Micó, J. A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.006 · Cited by 40
Faron‐Górecka, A., Kuśmider, M., İnan, S. Y., Siwanowicz, J., Piwowarczyk, T., & Dziedzicka‐Wasylewska, M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.011 · Cited by 40
Celano, E., Tiraboschi, E., Consogno, E., D’Urso, G., Mbakop, M. P., Gennarelli, M., de Bartolomeis, A., Racagni, G., & Popoli, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01491-9 · Cited by 40
Noradrenergic Function and Clinical Outcome in Antidepressant Pharmacotherapy
Miller, H., Ekstrom, R. D., Mason, G. A., Lydiard, R. B., & Golden, R. N. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00232-3 · Cited by 40
Eisenhofer, G., McCarty, R. C., Pacák, K., Russ, H., Sch�mig, E., & Eisenhofer, G. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00171059 · Cited by 40
Rosa, M. L. N. M., Guimarães, F. S., Pearson, R. C. A., & Bel, E. A. D. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00859-6 · Cited by 40
Switching to tianeptine in patients with antidepressant‐induced sexual dysfunction
Atmaca, M., Kuloğlu, M., Tezcan, E., & Buyukbayram, A. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.479 · Cited by 40
GABA, depression and the mechanism of action of antidepressant drugs: a neuroendocrine approach
Monteleone, P., Maj, M., Iovino, M., & Steardo, L. (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90043-8 · Cited by 40
Is noradrenaline a significant factor in the analgesic effect of antidepressants?
Jasmin, L., Tien, D. A., Janni, G., & Ohara, P. T. (2003) · Pain · doi:10.1016/j.pain.2003.08.010 · Cited by 40
Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40
Lithium addition in treatment-resistant depression
de Montigny, C. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199406002-00006 · Cited by 40
Popova, N. K., & Amstislavskaya, T. G. (2002) · Neuroendocrinology · doi:10.1159/000063681 · Cited by 39
Mechanism of action of A-85380 in an animal model of depression
Buckley, M. J., Surowy, C. S., Meyer, M., & Curzon, P. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.012 · Cited by 39
Przegaliński, E., Budziszewska, B., Siwanowicz, J., & Jaworska, L. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90036-3 · Cited by 39
Relief of SSRI-Induced Sexual Dysfunction With Mirtazapine Treatment
Farah, A. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0412a · Cited by 39
McAllister-Williams, H., & Rugg, M. D. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0938-5 · Cited by 39
Rowe, W. B., O’Donnell, J.-P., Pearson, D., Rose, G. M., Meaney, M. J., & Quirion, R. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00116-5 · Cited by 39
Lepine, J. P., Altamura, C. A., Ansseau, M., Gutiérrez, J. L., Bitter, I., LADER, M. H., & Waintraub, L. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.289 · Cited by 39
Pharmacotherapy response and diagnostic validity in atypical depression
Sotsky, S. M., & Simmens, S. J. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00014-2 · Cited by 39
Millan, M. J., Brocco, M., Veiga, S., Cistarelli, L., Melon, C., & Gobert, A. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01445-3 · Cited by 39
Self-citation
Cited by
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citationMulti-target-Directed Ligands To Combat Neurodegenerative Diseases
Cavalli, A., Bolognesi, M. L., Minarini, A., Rosini, M., Tumiatti, V., Recanatini, M., & Melchiorre, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7009364 · Cited by 1,152
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Metadata
- Authors
- Millan, M. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 110
- Issue
- 2
- Pages
- 135-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2073570537
- Cited by
- 551
- References
- 3,517
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.